In the current study, we investigated the CD3+ T cells, CD4+ T cells, CD8+ T cells, CD68+ macrophages, NK cells, and FOXP3+ Tregs populations in HCC by immunohistochemistry (IHC), and evaluated the relationship between these findings and clinical outcomes. This evidence concerns the gene FOXP3 and hepatocellular carcinoma.